Maskrey, Taber
(2021)
Synthetic Studies of Heterocyclic and Bioactive Agents.
Doctoral Dissertation, University of Pittsburgh.
(Unpublished)
Abstract
This dissertation describes a novel one-pot preparation of bicyclic heterocycles and improved synthetic procedures for the production of compounds possessing established biological activity. A five-component condensation reaction was discovered that follows a mechanistic sequence starting with a Biginelli reaction and ending in a Diels-Alder reaction to form a new class of bicyclic heterocycles. New protocols were developed to synthesize the bioactive compounds Gefitinib and analogs of JP4-039. The FDA approved EGFR inhibitor Gefitinib was synthesized on a pilot-plant scale using a more efficient synthetic sequence and fewer hazardous reagents. A shorter synthetic sequence to ferroptosis inhibitors, JP4-039 and related analogs, was developed with a key vinylogous Mannich reaction utilizing an oxazolidinone auxiliary. The biological activity of new ferroptosis inhibitors was used to generate a structure-activity relationship (SAR) hypothesis.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
University of Pittsburgh ETD
|
Status: |
Unpublished |
Creators/Authors: |
|
ETD Committee: |
|
Date: |
3 May 2021 |
Date Type: |
Publication |
Defense Date: |
17 March 2021 |
Approval Date: |
3 May 2021 |
Submission Date: |
15 March 2021 |
Access Restriction: |
No restriction; Release the ETD for access worldwide immediately. |
Number of Pages: |
237 |
Institution: |
University of Pittsburgh |
Schools and Programs: |
Dietrich School of Arts and Sciences > Chemistry |
Degree: |
PhD - Doctor of Philosophy |
Thesis Type: |
Doctoral Dissertation |
Refereed: |
Yes |
Uncontrolled Keywords: |
5-component-condensation reaction, Gefitinib, JP4-039, ferroptosis, vinylogous Mannich reaction |
Date Deposited: |
03 May 2021 14:46 |
Last Modified: |
03 May 2021 14:46 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/40373 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Actions (login required)
|
View Item |